U.S. Breast Reconstruction Market Size & Outlook
U.S. breast reconstruction market, 2018-2030 (US$M)
Related Markets
U.S. breast reconstruction market highlights
- The U.S. breast reconstruction market generated a revenue of USD 72.2 million in 2023 and is expected to reach USD 113.4 million by 2030.
- The U.S. market is expected to grow at a CAGR of 6.7% from 2024 to 2030.
- In terms of segment, tissue expander was the largest revenue generating product in 2023.
- Tissue Expander is the most lucrative product segment registering the fastest growth during the forecast period.
Breast reconstruction market data book summary
| Market revenue in 2023 | USD 72.2 million |
| Market revenue in 2030 | USD 113.4 million |
| Growth rate | 6.7% (CAGR from 2023 to 2030) |
| Largest segment | Tissue expander |
| Fastest growing segment | Tissue Expander |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Tissue Expander, Acellular Dermal Matrix |
| Key market players worldwide | Johnson & Johnson, AbbVie Inc, Sientra Inc, Establishment Labs Holdings Inc, Integra Lifesciences Holdings Corp, GC Aesthetics, Ideal Implant, Polytech Health & Aesthetics, RTI Surgical - OEM Business, Laboratoires Sebbin |
Other key industry trends
- In terms of revenue, U.S. accounted for 38.0% of the global breast reconstruction market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. breast reconstruction market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 20.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Breast Reconstruction Market Scope
Breast Reconstruction Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. breast reconstruction market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to breast reconstruction market will help companies and investors design strategic landscapes.
Tissue expander was the largest segment with a revenue share of 63.99% in 2023. Horizon Databook has segmented the U.S. breast reconstruction market based on tissue expander, acellular dermal matrix covering the revenue growth of each sub-segment from 2018 to 2030.
Some of the key players in the breast reconstruction market, headquartered in the U.S., include Allergan (now part of AbbVie); Mentor (a subsidiary of Johnson & Johnson); Sientra, Establishment Labs S.A.; and Ideal Implant Incorporated.
Due to the presence of leading players in the country, the market is highly competitive. Market players are undertaking various initiatives to strengthen their presence in the country.
Reasons to subscribe to U.S. breast reconstruction market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. breast reconstruction market databook
-
Our clientele includes a mix of breast reconstruction market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. breast reconstruction market , including forecasts for subscribers. This country databook contains high-level insights into U.S. breast reconstruction market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. breast reconstruction market size, by product, 2018-2030 (US$M)
U.S. Breast Reconstruction Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
